Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Addex Therapeutics Ltd market cap is $69.89M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Addex Therapeutics Ltd 52 week high is $0.99 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Addex Therapeutics Ltd 52 week low is $0.99 as of November 18, 2026.
Addex Therapeutics Ltd stock price today is $0.99.
Addex Therapeutics Ltd stock price yesterday was $1.56.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Addex Therapeutics Ltd's P/E ratio is -1.67.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Addex Therapeutics Ltd P/B ratio is 6.514.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Addex Therapeutics Ltd 50-day moving average is $0.99.